Your browser doesn't support javascript.
loading
Heparanase and Type 1 Diabetes.
Simeonovic, Charmaine J; Popp, Sarah K; Brown, Debra J; Li, Fei-Ju; Lafferty, Antony R A; Freeman, Craig; Parish, Christopher R.
Afiliação
  • Simeonovic CJ; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia. Charmaine.Simeonovic@anu.edu.au.
  • Popp SK; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Brown DJ; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Li FJ; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Lafferty ARA; Department of Paediatrics, The Canberra Hospital, Woden, ACT, Australia.
  • Freeman C; The ANU Medical School, The Australian National University, Canberra, ACT, Australia.
  • Parish CR; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Adv Exp Med Biol ; 1221: 607-630, 2020.
Article em En | MEDLINE | ID: mdl-32274728

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Glucuronidase Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Glucuronidase Idioma: En Ano de publicação: 2020 Tipo de documento: Article